Alice Garnier

1.8k total citations
73 papers, 653 citations indexed

About

Alice Garnier is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Alice Garnier has authored 73 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 24 papers in Oncology and 24 papers in Immunology. Recurrent topics in Alice Garnier's work include Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (21 papers) and Immune Cell Function and Interaction (10 papers). Alice Garnier is often cited by papers focused on Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (21 papers) and Immune Cell Function and Interaction (10 papers). Alice Garnier collaborates with scholars based in France, United States and Canada. Alice Garnier's co-authors include Pierre Péterlin, Patrice Chevallier, Thierry Guillaume, Amandine Le Bourgeois, Marie C. Béné, Philippe Moreau, Marianne Coste‐Burel, Viviane Dubruille, Cyrille Touzeau and Beatrice Mahé and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Alice Garnier

65 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alice Garnier France	15	391	220	202	117	83	73	653
Marie Thérèse Rubio France	14	229 0.6×	182 0.8×	224 1.1×	85 0.7×	129 1.6×	39	561
Silvy Lachance Canada	15	331 0.8×	240 1.1×	178 0.9×	65 0.6×	118 1.4×	67	616
Carolina Martínez‐Laperche Spain	15	354 0.9×	126 0.6×	128 0.6×	65 0.6×	105 1.3×	61	587
Sakhila Ghimire Germany	10	387 1.0×	157 0.7×	311 1.5×	73 0.6×	140 1.7×	20	692
Pascual Balsalobre Spain	17	462 1.2×	252 1.1×	141 0.7×	97 0.8×	102 1.2×	57	782
Birte Wistinghausen United States	11	266 0.7×	293 1.3×	291 1.4×	172 1.5×	54 0.7×	29	705
Fábio R. Kerbauy Brazil	11	291 0.7×	153 0.7×	87 0.4×	61 0.5×	48 0.6×	45	474
Sandeep Nagra United Kingdom	13	351 0.9×	143 0.7×	134 0.7×	35 0.3×	61 0.7×	21	518
Patricia Walker Australia	14	248 0.6×	144 0.7×	137 0.7×	80 0.7×	192 2.3×	54	628
Pierre Péterlin France	18	670 1.7×	347 1.6×	313 1.5×	154 1.3×	170 2.0×	108	1.0k

Countries citing papers authored by Alice Garnier

Since Specialization

Citations

This map shows the geographic impact of Alice Garnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Garnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Garnier more than expected).

Fields of papers citing papers by Alice Garnier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Garnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Garnier. The network helps show where Alice Garnier may publish in the future.

Co-authorship network of co-authors of Alice Garnier

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Garnier. A scholar is included among the top collaborators of Alice Garnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Garnier. Alice Garnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chevallier, Patrice, Anne C. M. Thiébaut, Sylvie François, et al.. (2025). A phase II study of ponatinib for prevention of relapse after allotransplantation in <i>FLT3</i> internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial. Haematologica. 110(10). 2525–2529. 1 indexed citations

Willem, Catherine, Gaëlle David, Nolwenn Legrand, et al.. (2025). Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity. Blood Advances. 10(3). 665–681.

Adès, Lionel, Thomas Cluzeau, Thibault Comont, et al.. (2024). Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study. Blood. 144(Supplement 1). 351–351. 3 indexed citations

Lecomte, R., J. Graveleau, Yannick Le Bris, et al.. (2024). Susceptibility to mycobacterial infection in VEXAS syndrome. Lara D. Veeken. 64(2). 831–835. 10 indexed citations

Platzbecker, Uwe, Steven Lane, Alice Garnier, et al.. (2024). A Phase II Study Evaluating the Efficacy and Safety of Imetelstat in Patients with Advanced Myelodysplastic Neoplasms or AML Failing HMA-Based Therapy - Interim Analysis Results of the Impress Study. Blood. 144(Supplement 1). 3222–3222.

Péterlin, Pierre, Alice Garnier, Amandine Le Bourgeois, et al.. (2024). Successful Treatment of Congenital Erythropoietic Porphyria Using Matched Unrelated Hematopoietic Stem Cell Transplantation in an Adult: A Case Report. SHILAP Revista de lepidopterología. 4(2). e342–e342. 1 indexed citations

Forcade, Édouard, Louis Terriou, Alice Garnier, et al.. (2024). Efficacy and Safety of Pegcetacoplan in PNH Patients with Extra-Vascular Hemolysis Under Anti-C5: The Real-Life Experience of the National French Reference Center. Blood. 144(Supplement 1). 1321–1321. 1 indexed citations

Bris, Yannick Le, Catherine Godon, Olivier Pichon, et al.. (2023). Optical Genome Mapping Combined with High-Throughput Sequencing Is Effective for the Diagnostic and Prognostic Genomic Classification of Acute Myeloid Leukemia and Myelodysplastic Neoplasms. Blood. 142(Supplement 1). 6051–6051.

Péterlin, Pierre, Alice Garnier, Amandine Le Bourgeois, et al.. (2023). Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial. EClinicalMedicine. 64. 102254–102254. 5 indexed citations

10.

Péterlin, Pierre, Alice Garnier, Amandine Le Bourgeois, et al.. (2023). First-in-human trial of tocilizumab in combination with a standard induction chemotherapy in newly diagnosed acute myeloid leukemia patients: The phase 1 TOCILAM study.. Journal of Clinical Oncology. 41(16_suppl). 7028–7028. 1 indexed citations

11.

Péterlin, Pierre, Alice Garnier, Amandine Le Bourgeois, et al.. (2022). Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report. Acta Haematologica. 145(5). 537–541. 8 indexed citations

12.

Bourgeois, Amandine Le, Marianne Coste‐Burel, Pierre Péterlin, et al.. (2022). B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(5). 279.e1–279.e4. 9 indexed citations

13.

Devillier, Raynier, Édouard Forcade, Alice Garnier, et al.. (2021). In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study. Blood Advances. 6(6). 1804–1812. 17 indexed citations

14.

Bernard, Claire, et al.. (2021). Geographical Indication Building Process for Sharr Cheese (Kosovo): “Inside Insights” on Sustainability. Sustainability. 13(10). 5696–5696. 6 indexed citations

15.

Lok, Anne, Benoît Tessoulin, Thomas Gastinne, et al.. (2020). Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life. Annals of Hematology. 99(7). 1595–1604. 30 indexed citations

16.

Tessoulin, Benoît, Nicolas Blin, Thomas Gastinne, et al.. (2019). Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study. Annals of Hematology. 98(6). 1441–1447. 11 indexed citations

17.

Bodet‐Milin, Caroline, Clément Bailly, Thierry Guillaume, et al.. (2018). Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients. Biology of Blood and Marrow Transplantation. 25(5). 906–911. 3 indexed citations

18.

Péterlin, Pierre, Thierry Guillaume, Alice Garnier, et al.. (2018). Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases. Leukemia Research Reports. 9. 16–17. 1 indexed citations

19.

Tessoulin, Benoît, Thomas Gastinne, Philippe Moreau, et al.. (2017). Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas. Annals of Hematology. 96(6). 943–950. 9 indexed citations

20.

Dirou, S., Arnaud Chambellan, Patrice Chevallier, et al.. (2017). Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 53(3). 281–290. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact